Effect of age and degree of immune activation on cytochrome P450 3A4 activity after influenza immunization

Pharmacotherapy

Volumn 22, Issue 10, 2002, Pages 1235-1238

  Hayney, Mary S ^a   Buck, Jessica M ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 3A4; ERYTHROMYCIN; INFLUENZA VACCINE; VIRUS ANTIBODY; CYP3A PROTEIN, HUMAN; CYP3A4 PROTEIN, HUMAN; CYTOCHROME P450; DIAGNOSTIC AGENT;

ADULT; AGE; ANTIBODY TITER; ARTICLE; BREATH ANALYSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION COEFFICIENT; DRUG ACTIVITY; DRUG INDUCED DISEASE; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN EXPERIMENT; IMMUNOREACTIVITY; INFLUENZA VACCINATION; MALE; NORMAL HUMAN; SEX; ANTIBODY PRODUCTION; IMMUNOLOGY; METABOLISM; MIDDLE AGED; SEX DIFFERENCE;

ADULT; AGE FACTORS; ANTIBODY FORMATION; BREATH TESTS; CYTOCHROME P-450 ENZYME SYSTEM; ERYTHROMYCIN; FEMALE; HUMANS; INFLUENZA VACCINES; MALE; MIDDLE AGED; SEX FACTORS;

EID: 0036795294     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.22.15.1235.33477     Document Type: Article

References (27)

1. Smith CD, Bledsoe MA, Curran R, Green L, Lewis J. Effect of influenza vaccine on serum concentrations of total and free phenytoin. Clin Pharm 1988;7:828-32.
2. Jann MW, Fidone GS. Effect of influenza vaccine on serum anticonvulsant concentrations. Clin Pharm 1986;5:817-20.
3. Levine M, Jones MW, Gribble M. Increased serum phenytoin concentration following influenza vaccination. Clin Pharm 1984;3:505-9.
4. Plotkin E, Bernheim J, Ben-Chetrit S, Mor A, Korzets Z. Influenza vaccine: a possible trigger of rhabdomyolysis-induced acute renal failure due to the combined use of cerivastatin and bezafibrate. Nephrol Dial Transplant 2000;15:740-1.
5. Renton KW, Gray JD, Hall RI. Decreased elimination of theophylline after influenza vaccination. Can Med Assoc J 1980;123:288-90.
6. Meredith CG, Christian CD, Johnson RF, Troxell R, Davis GL, Schenker S. Effects of influenza virus vaccine on hepatic drug metabolism. Clin Pharmacol Ther 1985;37:396-401.
7. Gomolin IH, Chapron DJ, Luhan PA. Lack of effect of influenza vaccine on theophylline levels and warfarin anticoagulation in the elderly. J Am Geriatr Soc 1985;33:269-72.
8. Hannan SE, May JJ, Pratt DS, Richtsmeier WJ, Bertino JS Jr. The effect of whole virus influenza vaccination on theophylline pharmacokinetics. Am Rev Respir Dis 1988;137:903-6.
9. Hayney MS, Hammes RJ, Fine JP, Bianco JA. Effect of influenza immunization on CYP3A4 activity. Vaccine 2002;20:858-61.
10. Kim RB, Wilkinson GR. CYP2E1 activity is not altered by influenza vaccination [letter]. Br J Clin Pharmacol 1996;42:529-30.
11. Scavone J, Blyden G, Greenblatt D. Lack of effect of influenza vaccine on the pharmacokinetics of antipyrine, alprazolam, paracetamol (acetaminophen) and lorazepam. Clin Pharmacokinet 1989;16:180-5.
12. Kinirons MT, Crome P. Clinical pharmacokinetic considerations in the elderly: an update. Clin Pharmacokinet 1997;33:302-12.
13. Hunt CM, Westerkam WR, Stave GM. Effect of age and gender on the activity of human hepatic CYP3A. Biochem Pharmacol 1992;44:275-83.
14. Centers for Disease Control and Prevention. Prevention and control of influenza: recommendations of the advisory committee on immunization practices (AC1P). MMWR Morb Mortal Wkly Rep 2002;51:1-31.
15. Watkins PB. Noninvasive tests of CYP3A enzymes. Pharmacogenetics 1994;4:171-84.
16. Shimada T, Yamazaki H, Mimura M, Inui Y, Guengerich FP. Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther 1994;270:414-23.
17. Turgeon DK, Leichtman AB, Lown KS, et al. P450 3A activity and cyclosporine dosing in kidney and heart transplant recipients. Clin Pharmacol Ther 1994;56:253-60.
18. Chiou WL, Jeong HY, Wu TC, Ma C. Use of the erythromycin breath test for in vivo assessments of cytochrome P4503A activity and dosage individualization. Clin Pharmacol Ther 2001;70:305-10.
19. Abdel-Razzak Z, Loyer P, Fautrel A, et al. Cytokines down-regulate expression of major cytochrome P-450 enzymes in adult human hepatocytes in primary culture. Mol Pharmacol 1993;44:707-15.
20. Tapner M, Liddle C, Goodwin B, George J, Farrell GC. Interferon gamma down-regulates cytochrome P450 3A genes in primary cultures of well-differentiated rat hepatocytes. Hepatology 1996;24:367-73.
21. Tinel M, Robin MA, Doostzadeh J, et al. The interleukin-2 receptor down-regulates the expression of cytochrome P450 in cultured rat hepatocytes. Gastroenterology 1995;109:1589-99.
22. Cantoni L, Carelli M, Ghezzi P, Delgado R, Faggioni R, Rizzardini M. Mechanisms of interleukin-2-induced depression of hepatic cytochrome P-450 in mice. Eur J Pharmacol 1995;292:257-63.
23. Chen JQ, Strom A, Gustafsson JA, Morgan ET. Suppression of the constitutive expression of cytochrome P-450 2C11 by cytokines and interferons in primary cultures of rat hepatocytes: comparison with induction of acute-phase genes and demonstration that CYP2C11 promoter sequences are involved in the suppressive response to interleukins 1 and 6. Mol Pharmacol 1995;47:940-7.
24. Gidal BE, Reiss WG, Liao JS, Pitterle ME. Changes in interleukin-6 concentrations following epilepsy surgery: potential influence on carbamazepine pharmacokinetics [letter]. Ann Pharmacother 1996;30:545-6.
25. Powers DC, Belshe RB. Effect of age on cytotoxic T lymphocyte memory as well as serum and local antibody responses elicited by inactivated influenza virus vaccine. J Infect Dis 1993;167:584-92.
26. Powers DC, Hanscome PJ, Pietrobon PJ. In previously immunized elderly adults inactivated influenza A (H1N1) virus vaccines induce poor antibody responses that are not enhanced by liposome adjuvant. Vaccine 1995;13:1330-5.
27. Dorrell L, Hassan I, Marshall S, Chakraverty P, Ong E. Clinical and serological responses to an inactivated influenza vaccine in adults with HIV infection, diabetes, obstructive airways disease, elderly adults and healthy volunteers. Int J STD AIDS 1997;8:776-9.